Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Molecules ; 28(23)2023 Dec 03.
Artículo en Inglés | MEDLINE | ID: mdl-38067642

RESUMEN

(1) Background: almond peels are rich in polyphenols such as catechin and epicatechin, which are important anti-free-radical agents, anti-inflammatory compounds, and capable of breaking down cholesterol plaques. This work aims to evaluate the biological and technological activity of a "green" dry aqueous extract from Sicilian almond peels, a waste product of the food industry, and to develop healthy nutraceuticals with natural ingredients. Eudraguard® Natural is a natural coating polymer chosen to develop atomized formulations that improve the technological properties of the extract. (2) Methods: the antioxidant and free radical scavenger activity of the extract was rated using different methods (DPPH assay, ABTS, ORAC, NO). The metalloproteinases of the extracts (MMP-2 and MMP-9), the enhanced inhibition of the final glycation products, and the effects of the compounds on cell viability were also tested. All pure materials and formulations were characterized using UV, HPLC, FTIR, DSC, and SEM methods. (3) Results: almond peel extract showed appreciable antioxidant and free radical activity with a stronger NO inhibition effect, strong activity on MMP-2, and good antiglycative effects. In light of this, a food supplement with added health value was formulated. Eudraguard® Natural acted as a swelling substrate by improving extract solubility and dissolution/release (4) Conclusions: almond peel extract has significant antioxidant activity and MMP/AGE inhibition effects, resulting in an optimal candidate to formulate safe microsystems with potential antimetabolic activity. Eudraguard® Natural is capable of obtaining spray-dried microsystems with an improvement in the extract's biological and technological characteristics. It also protects the dry extract from degradation and oxidation, prolonging the shelf life of the final product.


Asunto(s)
Antioxidantes , Prunus dulcis , Antioxidantes/farmacología , Antioxidantes/química , Metaloproteinasa 2 de la Matriz , Extractos Vegetales/farmacología , Extractos Vegetales/química , Suplementos Dietéticos , Radicales Libres/química
2.
Planta Med ; 85(3): 258-265, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30206907

RESUMEN

Crocin and crocetin are two interesting constituents of saffron (Crocus sativus) that possess important biological activities. Their use as therapeutic agents is strongly compromised by a scarce stability, poor absorption, and low bioavailability. Therefore, to improve these unfavorable features, the aim of the present work has been to apply a nanotechnological approach based on the formulation of solid lipid nanoparticles containing crocin and crocetin. Solid lipid nanoparticles were formulated according to crocin and crocetin chemical properties, using a variation of the quasi-emulsion solvent diffusion method to formulate crocin-solid lipid nanoparticles, while crocetin-solid lipid nanoparticles were prepared following the solvent diffusion method. Morphology and dimensional distribution of solid lipid nanoparticles have been characterized by differential scanning calorimetry and photon correlation spectroscopy, respectively, while the effect of drug incorporation versus time has been studied by Turbiscan technology. In order to verify the role of the nanotechnological approach on the biological activities of crocin and crocetin, the antioxidant and antiproliferative effects of these carotenoids once incorporated in lipid nanoparticles have been evaluated. For this aim, the oxygen radical absorbance capacity assay and the MTT test were used, respectively.The results pointed out the formulation of nanometric dispersions endowed with high homogeneity and stability, with an encapsulation efficiency ranging from 80 (crocetin-solid lipid nanoparticles) to 94% (crocin-crocetin). The oxygen radical absorbance capacity assay evidenced an interesting and prolonged antioxidant activity of crocin and crocetin once encapsulated in solid lipid nanoparticles, while the nanoencapsulation strategy showed a different mechanism in ameliorating the cytotoxic effect of these two substances.


Asunto(s)
Antioxidantes/administración & dosificación , Carotenoides/administración & dosificación , Citotoxinas/administración & dosificación , Antineoplásicos/administración & dosificación , Antineoplásicos/farmacocinética , Antioxidantes/farmacocinética , Disponibilidad Biológica , Carotenoides/farmacocinética , Línea Celular Tumoral , Citotoxinas/farmacocinética , Sistemas de Liberación de Medicamentos , Humanos , Nanopartículas , Vitamina A/análogos & derivados
3.
Oxid Med Cell Longev ; 2017: 2867630, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29230268

RESUMEN

Alginate and ß-cyclodextrin were used to produce easily dosable and spray-dried microsystems of a dried blood orange extract with antidysmetabolic properties, obtained from a by-product fluid extract. The spray-dried applied conditions were able to obtain a concentrate dried extract without the loss of AOA and with TPC and TMA values of 35-40% higher than that of the starting material. They were also effective in producing microparticles with 80-100% of encapsulation efficiency. The 2% sodium alginate was capable of improving the extract shelf life, while the beta-cyclodextrin (1 : 1 molar ratio with dried extract) prolonged the extract antioxidant efficiency by 6 hours. The good inhibition effect of the dried extract on the AGE formation and the MMP-2 and MMP-9 activity is presumably due to a synergic effect exerted by both anthocyanin and bioflavonoid extract compounds and was improved by the use of alginate and cyclodextrin.


Asunto(s)
Alginatos/metabolismo , Antioxidantes/uso terapéutico , Citrus sinensis/química , Inhibidores de la Metaloproteinasa de la Matriz/uso terapéutico , Extractos Vegetales/química , Polifenoles/metabolismo , Antioxidantes/farmacología , Ácido Glucurónico/metabolismo , Ácidos Hexurónicos/metabolismo , Inhibidores de la Metaloproteinasa de la Matriz/farmacología
4.
Oxid Med Cell Longev ; 2017: 7503240, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28367273

RESUMEN

The aim of this study was to evaluate the antidegenerative effect in osteoarthritis damage of eriocitrin alone and eriocitrin formulated as innovative "dietary flavonoid supplement." A complexation between eriocitrin and hydroxypropyl ß-cyclodextrin by solubilization/freeze-drying method was performed. The complex in solution was evaluated by phase solubility studies and the optimal 1 : 2 flavanone/cyclodextrin molar ratio was selected. Hydroxypropyl ß-cyclodextrin was able to complex eriocitrin as confirmed by UV-Vis absorption, DSC, and FTIR studies. The complex formed increased the eriocitrin water solubility (from 4.1 ± 0.2 g·L-1 to 11.0 ± 0.1 g·L-1) and dissolution rate (from 37.0% to 100%) in 30 min. The in vitro studies exhibit the notion that eriocitrin and its complex inhibit AGEs in a similar manner because hydroxypropyl ß-cyclodextrin does not interfere with the flavanone intrinsic property. Instead, the presence of cyclodextrin improves eriocitrin antioxidant stability maintaining a high fluorescence value until 8 hours with respect to the pure materials. Moreover, hydroxypropyl ß-cyclodextrin showed moderate GAGs restoration acting synergistically with the complexed compound to maintain the structural chondrocytes integrity. The results point out that ERT/HP-betaCD complex possesses technological and biological characteristics able to obtain an easily soluble nutraceutical product, which reduces the degenerative and oxidative damage which occurs in osteoarthritis, and improve the patient compliance.


Asunto(s)
Suplementos Dietéticos , Flavonoides/farmacología , Estrés Oxidativo/efectos de los fármacos , 2-Hidroxipropil-beta-Ciclodextrina , Adulto , Rastreo Diferencial de Calorimetría , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Condrocitos/citología , Condrocitos/metabolismo , Composición de Medicamentos , Flavanonas/química , Flavanonas/farmacología , Flavanonas/uso terapéutico , Flavonoides/química , Flavonoides/uso terapéutico , Humanos , Osteoartritis/metabolismo , Osteoartritis/patología , Osteoartritis/prevención & control , Solubilidad , Espectrofotometría Ultravioleta , Espectroscopía Infrarroja por Transformada de Fourier , beta-Ciclodextrinas/química
5.
Planta Med ; 83(5): 398-404, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-27124246

RESUMEN

Sesamol is a natural phenolic compound extracted from Sesamum indicum seed oil. Sesamol is endowed with several beneficial effects, but its use as a topical agent is strongly compromised by unfavorable chemical-physical properties. Therefore, to improve its characteristics, the aim of the present work was the formulation of nanostructured lipid carriers as drug delivery systems for topical administration of sesamol.Two different nanostructured lipid carrier systems have been produced based on the same solid lipid (Compritol® 888 ATO) but in a mixture with two different kinds of oil phase such as Miglyol® 812 (nanostructured lipid carrier-M) and sesame oil (nanostructured lipid carrier-PLUS). Morphology and dimensional distribution of nanostructured lipid carriers have been characterized by differential scanning calorimetry and photon correlation spectroscopy, respectively. The release pattern of sesamol from nanostructured lipid carriers was evaluated in vitro determining drug percutaneous absorption through excised human skin. Furthermore, an oxygen radical absorbance capacity assay was used to determine their antioxidant activity.From the results obtained, the method used to formulate nanostructured lipid carriers led to a homogeneous dispersion of particles in a nanometric range. Sesamol has been encapsulated efficiently in both nanostructured lipid carriers, with higher encapsulation efficiency values (> 90 %) when sesame oil was used as the oil phase (nanostructured lipid carrier-PLUS). In vitro evidences show that nanostructured lipid carrier dispersions were able to control the rate of sesamol diffusion through the skin, with respect to the reference formulations.Furthermore, the oxygen radical absorbance capacity assay pointed out an interesting and prolonged antioxidant activity of sesamol, especially when vehiculated by nanostructured lipid carrier-PLUS.


Asunto(s)
Antioxidantes/administración & dosificación , Benzodioxoles/administración & dosificación , Nanoestructuras , Vehículos Farmacéuticos , Fenoles/administración & dosificación , Administración Tópica , Adulto , Antioxidantes/farmacología , Benzodioxoles/química , Benzodioxoles/farmacología , Humanos , Técnicas In Vitro , Lípidos , Estructura Molecular , Tamaño de la Partícula , Fenoles/química , Fenoles/farmacología , Absorción Cutánea
6.
Bioorg Med Chem ; 15(24): 7618-25, 2007 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-17889545

RESUMEN

5-Arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones (7,8) were synthesized and evaluated for their antidegenerative activity on human chondrocyte cultures stimulated by IL-1beta. This in vitro model has proven to be a useful experimental model to reproduce the mechanisms involved in arthritic diseases. The cell viability, the amount of GAGs, the production of NO and PGE(2) and the inhibition of MMP-3 were measured. Several thiazolidinones 7 and 8 exhibited the ability to block the production or action of the degenerative factors induced by IL-1beta.


Asunto(s)
Antiinflamatorios no Esteroideos/síntesis química , Antiinflamatorios no Esteroideos/farmacología , Condrocitos/efectos de los fármacos , Iminas/síntesis química , Modelos Biológicos , Tiazolidinas/síntesis química , Tiazolidinas/farmacología , Artritis/tratamiento farmacológico , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Condrocitos/inmunología , Evaluación Preclínica de Medicamentos , Humanos , Iminas/farmacología , Indometacina/farmacología , Interleucina-1beta/farmacología , Estándares de Referencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA